Making anti-cancer medicines accessible to the world.
Achieve a sustainable leadership in complex chemical synthesis for anticancer bulk drugs and finished dosages.
Care & value relations with open mind and trusts for a win-win relationship with all stake holders.
Growing with people
We value expertise, respect experience and believe in core strengths.
From humble begining at 1980's, approximately 38 years ago, Mr Vijay Batra, Chairman of the whole group promoted the company with the vision of "World class medicines to the world community". BDL has come a long way today to become one of the biggest indian company dedicated in cytotoxic API to world class facilities F&D; with strong portfolio across value chain.